New evidence of CV risk with testosterone therapy

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1484卷 / 1期
关键词：
D O I：
10.1007/s40278-014-8224-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [1] Testosterone therapy: increased risk of CV events
    Reactions Weekly, 2014, 1489 (1) : 2 - 2
  • [2] Testosterone products: increased risk of CV disorders
    Reactions Weekly, 2016, 1588 (1) : 4 - 4
  • [3] Testosterone replacement therapy increase risks of CV events
    Reactions Weekly, 2019, 1764 (1) : 13 - 13
  • [4] Testosterone therapy in men not linked to increased CV risks?
    Reactions Weekly, 2015, 1542 (1) : 13 - 13
  • [5] Testosterone therapy and mortality risk
    M L Eisenberg
    S Li
    D Herder
    D J Lamb
    L I Lipshultz
    International Journal of Impotence Research, 2015, 27 : 46 - 48
  • [6] Testosterone therapy and cancer risk
    Eisenberg, Michael L.
    Li, Shufeng
    Betts, Paul
    Herder, Danielle
    Lamb, Dolores J.
    Lipshultz, Larry I.
    BJU INTERNATIONAL, 2015, 115 (02) : 317 - 321
  • [7] Testosterone therapy and mortality risk
    Eisenberg, M. L.
    Li, S.
    Herder, D.
    Lamb, D. J.
    Lipshultz, L. I.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2015, 27 (02) : 46 - 48
  • [8] Testosterone therapy and cardiovascular risk
    Walsh, James P.
    Kitchens, Anne C.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (03) : 250 - 257
  • [9] New evidence on testosterone and cooperation
    Jack van Honk
    Estrella R. Montoya
    Peter A. Bos
    Mark van Vugt
    David Terburg
    Nature, 2012, 485 : E4 - E5
  • [10] Is Oral Testosterone the New Frontier of Testosterone Replacement Therapy?
    Ahmad, Syed W.
    Molfetto, Gianfranco
    Montoya, David
    Camero, Ariday
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
12345